ArticlePloS one2013

DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOs.

Xing-Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.